This trial will test the safety of two 5-day cycles of gallium given intravenously to adults with CF who also have an infection with NTM.
1 Primary · 2 Secondary · Reporting Duration: Day 6 to Day 111
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Gallium nitrate · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: